Skip to main content
CYCLOPHARM LIMITED logo

CYCLOPHARM LIMITED — Investor Relations & Filings

Ticker · CYC ISIN · AU000000CYC5 LEI · 9845008C9R4608FB7007 ASX Manufacturing
Open in API
Filings indexed 777 across all filing types
Latest filing 2021-02-16 Capital/Financing Update
Country AU Australia
Listing ASX CYC

About CYCLOPHARM LIMITED

https://www.cyclopharm.com.au

Cyclopharm Limited focuses on the development and commercialization of specialized medical imaging technologies. Its primary product, Technegas, is an ultra-fine dispersion of carbon nano-particles labeled with Technetium-99m, utilized for functional lung ventilation imaging. This technology is used to diagnose Pulmonary Embolism by providing high-resolution images via the inhalation of a radioactive aerosol. Technegas is generated on-site using proprietary equipment and is compatible with SPECT and SPECT/CT imaging. The system is engineered to provide diagnostic clarity even in patients with underlying airway diseases. Beyond its primary diagnostic use, the company investigates applications for its technology in managing chronic obstructive pulmonary disease (COPD), asthma, and lung cancer.

Recent filings

Filing Released Lang Actions
Cyclopharm Announces Results of Share Purchase Plan Offer 2 pages 111.7KB
Capital/Financing Update Classification · 95% confidence The document is an announcement from Cyclopharm Limited regarding the results of a Share Purchase Plan (SPP) offer, including details about the oversubscription, the amount raised, the issue price, and the intended use of the funds. It discusses capital raising activities and financing plans related to the company's expansion and product development. There are no financial statements or detailed financial performance data presented, nor is this a report or transcript. The content clearly relates to a capital raising update. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length (6607 characters) and detailed content support this classification with high confidence.
2021-02-16 English
Appendix 3B - Amended 13 pages 218.5KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form submitted to the ASX (Australian Securities Exchange) regarding a proposed issue of securities by Cyclopharm Limited. It details the terms and conditions of a securities purchase plan and a placement, including offer price, maximum number of securities, timetable, and compliance with ASX listing rules. The document is a formal announcement of a capital raising event, specifically the issuance of new shares under a securities purchase plan and placement. It is not a full financial report, earnings release, or management discussion, nor is it a regulatory certification or voting result. The content aligns with the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2021-02-16 English
Change in substantial holding - Barings 3 pages 395.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and relevant interests of a substantial shareholder in Cyclopharm Limited. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report, but a regulatory filing specifically about shareholding changes.
2021-02-09 English
Change in substantial holding - Chemical Overseas 3 pages 393.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and relevant interests of a substantial shareholder in Cyclopharm Limited. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2021-02-09 English
Change in substantial holding 3 pages 174.4KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001, specifically a "Notice of change of interests of substantial holder." It details changes in voting power and relevant interests of a substantial shareholder in Cyclopharm Limited. This type of filing is a notification of changes in major shareholdings, not a financial report, management announcement, or other types of filings. It matches the description of Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notice, not an announcement of a report or a certification. Therefore, the correct classification is MRQ.
2021-02-07 English
Cyclopharm Receives $3.1M R&D Tax Incentive for FY2020 1
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 5 February 2021 from Cyclopharm Limited regarding the receipt of a $3.1 million R&D tax incentive for the 2020 financial year. It is a brief announcement about a specific financial event (receipt of a tax incentive) rather than a full financial report or detailed analysis. The document does not contain financial statements or comprehensive financial data, nor does it present management discussion or earnings results. It is also not a regulatory certification or officer attestation. Given the short length (2896 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about a financial matter that does not fit into other specific categories like earnings release or capital update.
2021-02-04 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.